Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Acorda to commence phase II clinical trial of lead product for spinal cord injury

Feb. 16, 2000

Boehringer Ingelheim cation channel blocker tested in rat focal ischemia

Feb. 16, 2000

Favorable long-term data reported for AstraZeneca's atypical antipsychotic

Feb. 16, 2000

Humanized anti-E/P-selectin MAb from PDL shows promise as stroke Rx

Feb. 15, 2000

Stroke conference news: PD-98059 effective in cerebral vasospasm in dogs

Feb. 15, 2000

Neuroprotective effects of p38 MAP kinase inhibition confirmed in stroke model

Feb. 15, 2000

Neuroprotective and antiapoptotic effects of ebselen in mice with striatal ischemic injury

Feb. 15, 2000

Neuroprotection provided by new compounds synthesized at Monash University

Feb. 15, 2000

Solvay receives marketing exclusivity extension from FDA for Luvox

Feb. 15, 2000

Focal cerebral ischemic injury in rats improved by broad-spectrum ion channel blocker

Feb. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.